STORY HIGHLIGHTS Task force: Menopausal women should not use hormone therapy to prevent chronic disease Recommendation doesn’t apply to women under 50 managing menopausal symptoms Don’t undergo therapy if you don’t have symptoms of menopause, task force says (CNN) — The task force that sparked controversy with its breast cancer screening recommendations a few years ago — and PSA prostate-cancer screening pronouncements last week — is weighing in on hormone replacement therapy. But this time the U.S. Preventive Services Task Force recommendations are remarkable for their lack of controversy. The group says menopausal women should not use hormone therapy — estrogen either alone or combined with progestin — primarily to prevent chronic disease.
For the original version including any supplementary images or video, visit http://www.cnn.com/2012/05/29/health/conditions/hormone-replacement-therapy/
Can hormone therapy help protect the brain?
VIDEO By Andy Towle Lauren McNamara ( aka Zinnia Jones ), an activist and friend and former defense witness for Chelsea Manning explains why hormone therapy is a medical necessity for trans people and why Chelsea ought to be treated in prison: “We sentence people to incarceration. We do not sentence them to untreated medical conditions. We don’t sentence them to untreated gender dysphoria just as we don’t sentence them to untreated kidney failure, untreated infections, or anything else of the sort. When the government takes on inmates and incarcerates them, it becomes responsible for their medical care.
For the original version including any supplementary images or video, visit http://www.towleroad.com/2013/08/why-is-hormone-therapy-a-medical-necessity-for-chelsea-manning-video.html
Why is Hormone Therapy a Medical Necessity for Chelsea Manning? — VIDEO
Hear the urine metabolite test should next be on my list. Good luck everyone! October 26, 2012 at 10:20 | Report abuse | DrJohn Its not a sex bias because most of the grief comes from OB/GYNs, of which females outnumber males in that field. There are truly more risks for female HRT then male T replacement. The bias comes from the Women’s health study and failure to look at the re-analysis which clearly indicates that timing is the most important factor in determining benefits vs risk. Prior to that study, all my residency professors told us to talk to menopausal women about HRT and assess risks and benefits. Do a study of women 50-59 on Climara and bio-identical prometrium and the results would be far more positive, as they were in previous studies like the Nurse’s health study before WHI.
For the original version including any supplementary images or video, visit http://thechart.blogs.cnn.com/2012/10/24/can-hormone-therapy-help-protect-the-brain/